The FDA and FTC Regulatory Overlap Means Twice as Much Compliance for CBD Companies
Canna Law Blog
SEPTEMBER 23, 2019
Last week, the Federal Trade Commission (“FTC”) issued warning letters to three unnamed companies that advertised their CBD-infused products as treatments or cure for serious medical conditions. The distinction between labeling (including packaging) and advertising is not always clear. These warning letters are nothing new.
Let's personalize your content